rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
WELCURE DRUGS & PHARMACEUTICALS LTD. - Board Meeting Intimation for Prior Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Information Regarding Reopening Of Trading Window Of Equity Shares Of The Company.
Download announcement < Back
01 Feb 2023
WELCURE DRUGS &amp; PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve With reference to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that, a meeting of Board of Directors of the Company will be held on Monday, 13th February, 2023 at 2:30 P.M. at the registered office of the Company, interalia, to transact the following matters: 1. To consider, approve &amp; take on record the Un-Audited Financial Results of the Company for the quarter ended 31st December, 2022 along with Limited Review Report. 2. To consider, review and approve the request received on 16th January, 2023 from Mr. Dharam Chand Jain, promoter of the company, seeking reclassification of its name from &apos;promoter and Promoter Group&apos; category to the &apos;public&apos; category . 3. Any other business as may be considered necessary. We further wish to inform you that as per requirement, the Trading Window of Equity Shares of the Company shall reopen on 16th February, 2023 for all designated persons of the Company.
View all announcements for WELCURE DRUGS & PHARMACEUTICALS LTD. Source: BSE India